The FDA approves generic drugs through the ANDA pathway under the Hatch-Waxman Act, ensuring they match brand-name drugs in safety, strength, and bioequivalence. Learn how the legal and scientific process makes generics affordable without compromising quality.
Learn how employer health plans use formularies to push generic drugs and control prescription costs. Understand tiers, PBMs, rebates, and how to save money on your meds.
Bioequivalence for inhalers, patches, and injections ensures generic drugs work like the originals-not just in blood levels, but in how they're delivered. Learn how regulators test these complex systems and why it matters for patient safety.
Learn how Medicare Part D covers generic drugs in 2025, including tiered pricing, the $2,000 out-of-pocket cap, and how to save hundreds annually by choosing the right plan.
The WHO Model List of Essential Medicines sets global standards for affordable, effective generics. Used by over 150 countries, it ensures life-saving medicines are available where they're needed most - even in the poorest health systems.
Media coverage often fuels public mistrust in generic drugs despite scientific proof they're just as safe and effective as brand-name versions. Learn how news stories shape perceptions-and what you can do to make smarter choices.
Learn how coupons, generics, and prior authorizations affect your medication costs in the U.S. Discover real ways to save money on prescriptions without sacrificing care.